FDLI - Enforcement, Litigation and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries
December 12, 2018 - December 13, 2018
STRATEGIC COMPLIANCE AND RISK MANAGEMENT
At PAREXEL Consulting, we believe that compliance and quality should be managed as any other critical business issue, and that by doing so, companies can reap the benefit of substantial ROI. The business benefits of proper quality management and maintaining a state of regulatory compliance will result in a reduction of direct costs such as reducing rejects to more indirect but substantial benefits such as eliminating adverse events and recalls.
Contact us today, so we can introduce you to our strategic Compliance and Risk-Management experts.
Request a meeting with our experts at our booth at FDLI in DC.
Wednesday, December 12, 2018 ~ 2:15pm - 3:10pm
Ensuring Manufacturing Compliance with Cell and Gene Therapies
Panelist: Mark Levi, Vice President, RCS - Compliance
Moderated by: Kalah Auchincloss, Sr. VP, Regulatory Compliance & Deputy General Counsel, Greenleaf Health, Inc.
Visit the FDLI website to view the full agenda and register to attend.
Can't make it to the FDLI Enforcement, Litigation, and Compliance Conference?
Click here to find out more about our clinical trial supply management services.